Kymera Therapeutics (KYMR) Stock Chart & Stock Price History → Things Are Not Normal in America – Here’s What to Do (From Stansberry Research) (Ad) Free KYMR Stock Alerts $39.22 +0.72 (+1.87%) (As of 11:16 AM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Kymera Therapeutics Stock Price Performance5 Day Performance+4.87%1 Month Performance+4.28%3 Month Performance+5.40%6 Month Performance+173.88%Year-To-Date Performance+54.05%1 Year Performance+41.44% Receive KYMR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Kymera Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyHow Biden has already won 2024Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that will forever enshrine Obama’s destructive, Marxist vision for America… A plot that could hand him and his allies near-total control over the government, your way of life, and your future.Click here to watch this now before it’s too late. KYMR Stock Chart for Thursday, May, 9, 2024 KYMR Chart by TradingView Kymera Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/08/2024$38.44$38.50+0.16%$38.91$37.65453,270 shs$2.36 billion05/07/2024$38.30$38.44+0.37%$39.06$38.08331,904 shs$2.36 billion05/06/2024$37.40$38.30+2.41%$38.52$37.19424,667 shs$2.35 billion05/03/2024$36.30$37.40+3.03%$38.21$36.06529,366 shs$2.29 billion05/02/2024$36.24$36.30+0.17%$36.83$35.06502,668 shs$2.23 billion05/01/2024$33.62$36.24+7.79%$37.80$33.52637,582 shs$2.22 billion Get the Latest News and Ratings for KYMR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kymera Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/30/2024$34.66$33.62-3.00%$34.44$33.55481,501 shs$2.06 billion04/29/2024$33.37$34.66+3.87%$34.71$33.67428,514 shs$2.13 billion04/26/2024$33.35$33.37+0.06%$34.13$33.22452,363 shs$2.04 billion04/25/2024$35.21$33.35-5.28%$34.29$32.75786,230 shs$2.04 billion04/24/2024$35.71$35.21-1.40%$36.26$34.67379,566 shs$2.15 billion04/23/2024$34.35$35.71+3.96%$37.01$34.49437,028 shs$2.18 billion04/22/2024$33.97$34.35+1.12%$35.37$33.85417,209 shs$2.10 billion04/19/2024$35.12$33.97-3.27%$35.53$33.35627,418 shs$2.08 billion04/18/2024$33.76$35.12+4.03%$35.57$33.67619,727 shs$2.15 billion04/17/2024$33.93$33.76-0.50%$34.41$33.17433,664 shs$2.06 billion04/16/2024$34.39$33.93-1.34%$34.76$33.58492,320 shs$2.07 billion04/15/2024$35.58$34.39-3.34%$35.82$34.20528,658 shs$2.10 billion04/12/2024$37.21$35.58-4.38%$36.89$34.75598,099 shs$2.17 billion04/11/2024$35.33$37.21+5.32%$37.32$35.43469,853 shs$2.27 billion04/10/2024$37.61$35.33-6.06%$36.43$35.07655,350 shs$2.16 billion04/09/2024$36.37$37.61+3.41%$37.64$35.98494,947 shs$2.30 billion04/08/2024$36.40$36.37-0.08%$37.18$35.96296,256 shs$2.22 billion04/05/2024$36.24$36.40+0.44%$37.16$35.27428,984 shs$2.22 billion04/04/2024$37.13$36.24-2.40%$38.05$36.04471,912 shs$2.21 billion04/03/2024$37.64$37.13-1.35%$38.09$36.59591,871 shs$2.27 billion04/02/2024$39.42$37.64-4.52%$38.66$36.76543,257 shs$2.30 billion04/01/2024$40.20$39.42-1.94%$40.55$38.21528,318 shs$2.41 billion03/29/2024$40.20$40.20$40.62$39.34544,045 shs$2.46 billion03/28/2024$40.17$40.20+0.07%$40.62$39.35544,033 shs$2.46 billion03/27/2024$39.49$40.17+1.72%$40.21$38.96612,526 shs$2.45 billion03/26/2024$39.50$39.49-0.03%$40.36$38.99382,438 shs$2.41 billion03/25/2024$40.72$39.50-3.00%$41.33$39.28302,017 shs$2.41 billion03/22/2024$40.82$40.72-0.24%$41.30$39.99323,323 shs$2.49 billion03/21/2024$40.33$40.82+1.21%$41.89$40.42644,597 shs$2.49 billion03/20/2024$39.57$40.33+1.92%$40.42$38.75695,976 shs$2.46 billion03/19/2024$39.32$39.57+0.64%$40.30$38.781.67 million shs$2.42 billion03/18/2024$40.58$39.32-3.10%$41.24$39.081.01 million shs$2.40 billion03/15/2024$39.51$40.58+2.71%$41.50$39.132.01 million shs$2.48 billion03/14/2024$42.30$39.51-6.60%$42.26$39.23889,106 shs$2.41 billionElon to Transform U.S. Economy? (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it.03/13/2024$41.85$42.30+1.08%$43.10$41.50742,475 shs$2.59 billion03/12/2024$42.29$41.85-1.04%$43.07$41.34670,293 shs$2.56 billion03/11/2024$43.49$42.29-2.76%$44.14$42.10516,198 shs$2.58 billion03/08/2024$42.70$43.49+1.85%$44.23$42.32378,183 shs$2.66 billion03/07/2024$41.90$42.70+1.91%$43.57$41.51533,341 shs$2.61 billion03/06/2024$41.90$41.90$43.24$41.07534,171 shs$2.49 billion03/05/2024$42.60$41.90-1.64%$42.60$41.52389,867 shs$2.49 billion03/04/2024$43.50$42.60-2.07%$44.14$41.03517,264 shs$2.53 billion03/01/2024$42.70$43.50+1.87%$44.97$42.92713,057 shs$2.58 billion02/29/2024$43.25$42.70-1.27%$44.59$42.58633,277 shs$2.53 billion02/28/2024$43.57$43.25-0.73%$44.27$42.69496,593 shs$2.57 billion02/27/2024$43.44$43.57+0.30%$45.31$43.16806,402 shs$2.59 billion02/26/2024$41.84$43.44+3.82%$44.55$41.60828,267 shs$2.58 billion02/23/2024$40.49$41.84+3.33%$42.15$40.03700,005 shs$2.48 billion02/22/2024$38.67$40.49+4.71%$42.68$38.80858,728 shs$2.25 billion02/21/2024$38.03$38.67+1.68%$39.22$37.39524,014 shs$2.15 billion02/20/2024$38.62$38.03-1.53%$39.39$37.91442,268 shs$2.11 billion02/19/2024$38.62$38.62$38.86$36.81542,100 shs$2.14 billion02/16/2024$37.42$38.62+3.21%$38.86$36.81541,557 shs$2.14 billion02/15/2024$36.87$37.42+1.49%$38.27$36.37997,386 shs$2.08 billion02/14/2024$35.03$36.87+5.25%$37.66$34.97602,671 shs$2.05 billion02/13/2024$36.41$35.03-3.79%$35.52$34.04883,552 shs$1.94 billion02/12/2024$37.21$36.41-2.15%$37.49$35.27727,540 shs$2.02 billion02/09/2024$33.98$37.21+9.51%$37.26$34.05741,572 shs$2.06 billion02/08/2024$33.79$33.98+0.56%$34.40$33.37578,178 shs$1.89 billion Related Companies: SANA Stock Chart APGE Stock Chart DNLI Stock Chart DNA Stock Chart VCEL Stock Chart RXRX Stock Chart FUSN Stock Chart TWST Stock Chart BEAM Stock Chart INBX Stock Chart Receive KYMR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Kymera Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:KYMR) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersThis 1 Biotech Stock has been shocking the marketsHuge Alerts1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kymera Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.